Precision Medicine in Israel 2020
The Precision Medicine Expert Mission travelled to Israel in February 2020. During the mission, a delegation of government representatives and precision medicine experts visited academic organisations, hospitals, government agencies and businesses to meet key stakeholders from the Israeli precision medicine ecosystem.
Abstract from outcome report:
The Ministry of Health approves new medicines and technologies in Israel and provides additional functions, including regulatory requirements such as ethics and consent to institutional review boards. The Ministry of Health also governs reimbursement coverage and plays a role in payment, with a system to prioritise new technologies with an assigned budget. Hence regulatory and reimbursement approval processes proceed more quickly in Israel than in the UK. The reimbursement and regulatory requirements in Israel appear to be less arduous than in the UK. Evidence requirements can also vary compared to the UK; for example, an economic value proposition is not necessarily required to gain reimbursement coverage.
The worldwide focus on personalised medicine to stratify, diagnose and treat patients is seen as a potential turning point in the Israel biopharma industry. Israel can combine expertise in biopharma and information technology to emerge as a player in the biopharma market.
Watch the recording below from our Dissemination Webinar which took place following the Expert Mission.
About Global Expert Missions
The Global Expert Missions (GEM) programme is funded by Innovate UK and designed to build international collaborations with governments, societies, enterprises, institutions, and people from every corner of the globe. With global challenges requiring international perspectives, the programme aims to support the UK government’s ambition to be the international partner of choice and a global hub for innovation by 2035.